Homologous Recombination Deficiency Associated With Response to Poly (ADP-ribose) Polymerase Inhibitors in Ovarian Cancer Patients: The First Real-World Evidence From China
Ni, Jing, Guo, Wenwen, Zhao, Qian, Cheng, Xianzhong, Xu, Xia, Zhou, Rui, Gu, Hongyuan, Chen, Chen, Chen, Xiaoxiang
Published in Frontiers in oncology (06.01.2022)
Published in Frontiers in oncology (06.01.2022)
Get full text
Journal Article
High Serpin Family A Member 10 Expression Confers Platinum Sensitivity and Is Associated With Survival Benefit in High-Grade Serous Ovarian Cancer: Based on Quantitative Proteomic Analysis
Guo, Wenwen, He, Xue, Ni, Jing, Ma, Liya, Cheng, Xianzhong, Wang, Congyang, Chen, Xiaoxiang, Wang, Yan
Published in Frontiers in oncology (23.11.2021)
Published in Frontiers in oncology (23.11.2021)
Get full text
Journal Article
Adverse Events as a Potential Clinical Marker of Antitumor Efficacy in Ovarian Cancer Patients Treated With Poly ADP-Ribose Polymerase Inhibitor
Ni, Jing, Cheng, Xianzhong, Zhou, Rui, Zhao, Qian, Xu, Xia, Guo, Wenwen, Gu, Hongyuan, Chen, Chen, Chen, Xiaoxiang
Published in Frontiers in oncology (06.09.2021)
Published in Frontiers in oncology (06.09.2021)
Get full text
Journal Article
The efficacy and safety of niraparib for ovarian cancer: a single-center observational study from China
Ni, Jing, Cheng, Xianzhong, Zhao, Qian, Dai, Zhiqin, Xu, Xia, Guo, Wenwen, Gu, Hongyuan, Zhou, Rui, Wang, Yan, Chen, Xiaoxiang
Published in Journal of ovarian research (17.05.2021)
Published in Journal of ovarian research (17.05.2021)
Get full text
Journal Article
Case Report: Extragonadal Yolk Sac Tumors Originating From the Endometrium and the Broad Ligament: A Case Series and Literature Review
Cheng, Xianzhong, Zhao, Qian, Xu, Xia, Guo, Wenwen, Gu, Hongyuan, Zhou, Rui, Chen, Chen, Ma, Dawei, Wu, Yinan, Ni, Jing, Chen, Xiaoxiang
Published in Frontiers in oncology (11.06.2021)
Published in Frontiers in oncology (11.06.2021)
Get full text
Journal Article
The value of secondary neoadjuvant chemotherapy in platinum-sensitive recurrent ovarian cancer: a case-control study post GOG-0213 trial
Gu, Hongyuan, Zhou, Rui, Ni, Jing, Xu, Xia, Cheng, Xianzhong, Li, Yan, Chen, Xiaoxiang
Published in Journal of ovarian research (16.06.2020)
Published in Journal of ovarian research (16.06.2020)
Get full text
Journal Article
Pathogenic Heteroplasmic Somatic Mitochondrial DNA Mutation Confers Platinum-Resistance and Recurrence of High-Grade Serous Ovarian Cancer
Ni, Jing, Wang, Yan, Cheng, Xianzhong, Teng, Fang, Wang, Congyang, Han, Suping, Chen, Xiaoxiang, Guo, Wenwen
Published in Cancer management and research (01.01.2020)
Published in Cancer management and research (01.01.2020)
Get full text
Journal Article
Synthesis, crystal structure, phosphate hydrolysis activity and antibacterial activity of macrocyclic dinuclear Zn(II) complex with benzyl pendant-arms
Kou, Huizhi, Wang, Yang, Ding, Peipei, Cheng, Xianzhong, Zhou, Guoqing
Published in Journal of molecular structure (15.09.2020)
Published in Journal of molecular structure (15.09.2020)
Get full text
Journal Article
Anlotinib as Exploratory Therapy for Platinum-Resistant Ovarian Cancer: A Retrospective Study on Efficacy and Safety
Ni, Jing, Cheng, Xianzhong, Chen, Jin, Guo, Wenwen, Dai, Zhiqin
Published in OncoTargets and therapy (01.01.2020)
Published in OncoTargets and therapy (01.01.2020)
Get full text
Journal Article
Homologous recombination deficiency associated with response to poly (ADP-ribose) polymerase inhibitors in ovarian cancer patients: The first real-word data from China
Chen, Xiaoxiang, Ni, Jing, Xu, Xia, Guo, Wenwen, Cheng, Xianzhong, Zhao, Qian, Zhou, Rui, Gu, Hongyuan, Chen, Chen
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Variance of HRD score from primary to recurrent in high-grade serous ovarian cancer
Chen, Xiaoxiang, Ni, Jing, Xu, Xia, Guo, Wenwen, Zhao, Qian, Cheng, Xianzhong, Zhou, Rui, Gu, Hongyuan, Chen, Chen
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Platinum Resistance After PARPi Resistance in a gBRCAmt Recurrent Ovarian Cancer Patient: a Case Report
Zhao, Qian, Ni, Jing, Dong, Jiayin, Cheng, Xianzhong, Xiao, Li, Xue, Qi, Xu, Xia, Guo, Wenwen, Chen, Xiaoxiang
Published in Reproductive sciences (Thousand Oaks, Calif.) (01.02.2023)
Published in Reproductive sciences (Thousand Oaks, Calif.) (01.02.2023)
Get full text
Journal Article
Adverse events as a potential clinical marker of antitumor efficacy in ovarian cancer patients treated with poly ADP-ribose polymerase (PARP) inhibitor
Ni, Jing, Chen, Xiaoxiang, Xu, Xia, Guo, Wenwen, Cheng, Xianzhong, Zhao, Qian, Gu, Hongyuan, Zhou, Rui, Chen, Chen
Published in Gynecologic oncology (01.08.2021)
Published in Gynecologic oncology (01.08.2021)
Get full text
Journal Article